Overall prognosis of acute and chronic musculoskeletal, widespread, and neuropathic pain in children and adolescents

Montgomery, Laura RC; Andreucci, Alessandro; Kamper, Steven J; Michaleff, Zoe A; Williams, Christopher M; Campbell, Paul; Dario, Amabile; van der Windt, Daniëlle AWM; Dunn, Kate M; Swain, Michael S

Abstract

Objectives
This is a protocol for a Cochrane Review (prognosis). The objectives are as follows:

We aim to describe the overall prognosis (focusing on the pain course) and the negative impact(s) of acute and chronic musculoskeletal, widespread, and neuropathic pain in children (aged six to 12 years) and adolescents (aged 13 to 18 years) by evaluating:

incidence of pain recovery at three and 12 months after reporting acute or chronic pain;
change in pain severity at three and 12 months after reporting acute or chronic pain; and
negative impact(s) of pain at three and 12 months after reporting chronic pain.

Citation

Dunn, K., Montgomery, L. R., Andreucci, A., Kamper, S. J., van der Windt, D., Michaleff, Z. A., …Swain, M. S. (2023). Overall prognosis of acute and chronic musculoskeletal, widespread, and neuropathic pain in children and adolescents. Cochrane Database of Systematic Reviews, 2023(2), https://doi.org/10.1002/14651858.cd014773

• Journal Article Type: Article
• Acceptance Date: Feb 28, 2023
• Online Publication Date: Feb 27, 2023
• Publication Date: Feb 27, 2023
• Publicly Available Date: Feb 28, 2024
• Journal: Cochrane Database of Systematic Reviews
• Publisher: Cochrane Collaboration
• Volume: 2023
• Issue: 2
• DOI: https://doi.org/10.1002/14651858.cd014773
• Keywords: Pharmacology (medical)
• Publisher URL: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014773/full
• Additional Information: Copyright © 2023 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.All information related to this article, including copyrights, can be found on the publisher website.